| 國立臺灣大學 |
2007 |
Clinical Implications of Minimal Residual Disease Monitoring by Quantitative Polymerase Chain Reaction in Acute Myeloid Leukemia Patients Bearing Nucleophosmin (Npm1) Mutations
|
周文堅; 唐季祿; 吳尚儒; 蔡偉; 姚明; 黃聖懿; 陳建源; 黃琦斐; 田蕙芬; CHOU, WEN-CHIEN; TANG, JIH-LUH; WU, SHANG-JU; TSAY, WOEI; YAO, MING; HUANG, SHANG-YI; CHEN, CHIEN-YUAN; HUANG, CHI-FEI; TIEN HWEI-FANG |
| 國立臺灣大學 |
2007-05 |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou, WC; Tang, JL; Wu, SJ; Tsay, W; Yao, M; Huang, SY; Huang, KC; Chen, CY; Huang, CF; Tien, HF |
| 臺大學術典藏 |
2007 |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Tang J.-L.; Chou W.-C.; SHANG-JU WU; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2007 |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
MING YAO; Huang S.-Y.; Tsay W.; Wu S.-J.; Tang J.-L.; Chou W.-C.; Tien H.-F.; Huang C.-F.; Huang K.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-06T03:58:50Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou W.-C.; JIH-LUH TANG; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:21Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou W.-C.; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; SHANG-YI HUANG; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-14T03:09:13Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
Chou W.-C.; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; KUO-CHIN HUANG; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:47Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
WEN-CHIEN CHOU; Tang J.-L.; Wu S.-J.; Tsay W.; Yao M.; Huang S.-Y.; Huang K.-C.; Chen C.-Y.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
HWEI-FANG TIEN; Huang C.-F.; Chen C.-Y.; Huang S.-Y.; Huang K.-C.; Yao M.; Tsay W.; Wu S.-J.; Tang J.-L.; Chou W.-C. |
| 國立成功大學 |
2020 |
Clinical implications of multiple glioblastomas: An analysis of prognostic factors and survival to distinguish from their single counterparts
|
Shieh, L.-T.;Guo, H.-R.;Chang, Y.-K.;Lu, N.-M.;Ho, S.-Y. |
| 臺大學術典藏 |
2022-09-21T23:32:42Z |
Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
|
Cheng, Yung Ting; JIAN-HUA HONG; YU-CHUAN LU; Chang, Yi Kai; Hung, Shih Chun; Feng, Kuo Kang; SHIH-PING LIU; PO-MING CHOW; HONG-CHIANG CHANG; CHUNG-HSIN CHEN; YEONG-SHIAU PU |
| 中山醫學大學 |
2020-04 |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Chien, Y.-L.; Hwu, H.-G.; Hwang, T.-J.; Hsieh, M.H.; Liu, C.-C.; Lin-Shiau, S.-Y.; Liu, C.-M. |
| 臺大學術典藏 |
2020-06-26T02:12:46Z |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Yi-Ling Chien;Hwu H.-G.;Hwang T.-J.;Hsieh M.H.;Liu C.-C.;Lin-Shiau S.-Y.;Liu C.-M.; YI-LING CHIEN; Hwu H.-G.; Hwang T.-J.; Hsieh M.H.; Liu C.-C.; Lin-Shiau S.-Y.; Liu C.-M. |
| 臺大學術典藏 |
2020 |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Liu C.-C.; Hwang T.-J.; MING-HSIEN HSIEH; Hwu H.-G.; Chien Y.-L.; Chien Y.-L.;Hwu H.-G.;Hwang T.-J.;Ming-Hsien Hsieh;Liu C.-C.;Lin-Shiau S.-Y.;Liu C.-M.; Lin-Shiau S.-Y.; Liu C.-M. |
| 臺大學術典藏 |
2020-10-23T11:54:44Z |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Chien Y.-L.;Hwu H.-G.;Tzung-Jeng Hwang;Hsieh M.H.;Liu C.-C.;Lin-Shiau S.-Y.;Liu C.-M.; Chien Y.-L.; Hwu H.-G.; TZUNG-JENG HWANG; Hsieh M.H.; Liu C.-C.; Lin-Shiau S.-Y.; Liu C.-M. |
| 臺大學術典藏 |
2021-08-13T03:35:03Z |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Chien Y.-L.; Hwu H.-G.; Hwang T.-J.; Hsieh M.H.; CHEN-CHUNG LIU; Lin-Shiau S.-Y.; Liu C.-M. |
| 臺大學術典藏 |
2021-10-22T07:39:38Z |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Chien Y.-L.; HAI-GWO HWU; Hwang T.-J.; Hsieh M.H.; Liu C.-C.; Lin-Shiau S.-Y.; Liu C.-M. |
| 臺大學術典藏 |
2021-09-23T08:02:04Z |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Chien Y.-L.; Hwu H.-G.; Hwang T.-J.; Hsieh M.H.; Liu C.-C.; Lin-Shiau S.-Y.; CHIH-MIN LIU |
| 中山醫學大學 |
2020 |
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
|
Chien, YL; Hwu, HG; Hwang, TJ; Hsieh, MH; Liu, CC; Lin-Shiau, SY; Liu, CM |
| 國立成功大學 |
2023-12 |
Clinical implications of PNA-sequencing as a complementary test for EGFR mutation analysis in human lung cancer
|
Chen;Yi-Lin;Lin;Chien-Chung;Yu;Yu-Ting;Chen;Wan-Li;Yang;Shu-Ching;Huang;Wenya;Su;Wu-Chou;Chow;Nan-Haw;Ho;Chung-Liang |
| 臺大學術典藏 |
2021-07-21T07:23:22Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; TIEN FENG-MING; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-06T01:58:43Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; MING YAO; Tien, Hwei-Fang |
| 臺大學術典藏 |
2021-07-07T04:42:35Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; Lin, Liang-In; WEN-CHIEN CHOU; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang; MING YAO |
| 臺大學術典藏 |
2021-07-15T05:31:45Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-11-24T07:19:27Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai, Cheng-Hong; Tang, Jih-Luh; TIEN FENG-MING; Kuo, Yuan-Yeh; Wu, Dung-Chi; CHIEN-CHIN LIN; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-01-10T08:54:12Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-25T05:32:21Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-08-04T16:44:39Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai, Cheng-Hong; Tang, Jih-Luh; Tien, Feng-Ming; Kuo, Yuan-Yeh; Wu, Dung-Chi; Lin, Chien-Chin; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; Tien F.-M.; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:23Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; FENG-MING TIEN; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T03:57:25Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H;Tang J.-L;Tien F.-M;Kuo Y.-Y;Wu D.-C;Lin C.-C;Tseng M.-H;Peng Y.-L;Hou M.-F;Chuang Y.-K;Liu M.-C;Liu C.-W;Yao M;Lin L.-I;Chou W.-C;Chen C.-Y;Hou H.-A;Tien H.-F.; Tsai C.-H; Tang J.-L; Tien F.-M; Kuo Y.-Y; Wu D.-C; Lin C.-C; Tseng M.-H; Peng Y.-L; Hou M.-F; Chuang Y.-K; Liu M.-C; Liu C.-W; Yao M; Lin L.-I; Chou W.-C; Chen C.-Y; Hou H.-A; Tien H.-F.; CHIEN-YU CHEN |
| 國立成功大學 |
2021-06 |
Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
|
Wu;I-Chin;Liu;Wen-Chun;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung |
| 臺大學術典藏 |
2018-09-10T06:41:10Z |
Clinical implications of short-axis aortopulmonary rotation on juxtacommissural origin of the coronary artery in transposition of the great arteries and surgical strategy
|
Chiu, I.-S. and Wu, M.-H. and Chang, C.-I. and Wang, J.-K. and Chen, M.-R. and Lin, S.-F. and Hung, C.-R.; MEI-HWAN WU; ING-SH CHIU; CHUNG-I CHANG |
| 臺大學術典藏 |
2020-03-04T08:52:50Z |
Clinical implications of short-axis aortopulmonary rotation on juxtacommissural origin of the coronary artery in transposition of the great arteries and surgical strategy
|
Chiu I.-S.; Wu M.-H.; CHUNG-I CHANG; Wang J.-K.; Chen M.-R.; Lin S.-F.; Hung C.-R. |
| 臺大學術典藏 |
2020-03-12T01:36:53Z |
Clinical implications of short-axis aortopulmonary rotation on juxtacommissural origin of the coronary artery in transposition of the great arteries and surgical strategy
|
Ing-Sh Chiu;Wu M.-H.;Chang C.-I.;Wang J.-K.;Chen M.-R.;Lin S.-F.;Hung C.-R.; ING-SH CHIU; Wu M.-H.; Chang C.-I.; Wang J.-K.; Chen M.-R.; Lin S.-F.; Hung C.-R. |
| 臺大學術典藏 |
2021-01-05T08:08:05Z |
Clinical implications of short-axis aortopulmonary rotation on juxtacommissural origin of the coronary artery in transposition of the great arteries and surgical strategy
|
Lin S.-F.; Chen M.-R.; Wang J.-K.; Chang C.-I.; MEI-HWAN WU; Chiu I.-S.;Mei-Hwan Wu;Chang C.-I.;Wang J.-K.;Chen M.-R.;Lin S.-F.;Hung C.-R.; Chiu I.-S.; Hung C.-R. |
| 臺大學術典藏 |
2021-01-06T05:51:00Z |
Clinical implications of short-axis aortopulmonary rotation on juxtacommissural origin of the coronary artery in transposition of the great arteries and surgical strategy
|
Chiu I.-S.;Wu M.-H.;Chang C.-I.;Jou-Kou Wang;Chen M.-R.;Lin S.-F.;Hung C.-R.; Chiu I.-S.; Wu M.-H.; Chang C.-I.; JOU-KOU WANG; Chen M.-R.; Lin S.-F.; Hung C.-R. |
| 國立臺灣大學 |
2006 |
Clinical Implications of Socs1 Methylation in Myelodysplastic Syndrome
|
吳尚儒; 姚明; 周文堅; 唐季祿; 陳建源; 柯博升; 黃聖懿; 蔡偉; 陳耀昌; 沈銘鏡; 王秋華; 葉又嘉; 田蕙芬; WU, SHANG-JU; YAO, MING; CHOU, WEN-CHIEN; TANG, JIH-LUH; CHEN, CHIEN-YUAN; KO, BO -SHENG; HUANG, SHANG-YI; TSAY, WOEI; CHEN, YAO-CHANG; SHEN, MING-CHING; WANG, CHIU-HWA; YEH, YO-CHIA; TIEN, HWEI-FANG |
| 國立臺灣大學 |
2006-06 |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
吳尚儒; 姚明; 周文堅; 唐季祿; 陳建源; 柯博升; 黃聖懿; 蔡偉; 陳耀昌; 沈銘鏡; 王秋華; 葉又嘉; 田蕙芬 |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Huang S.-Y.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Tang J.-L.; Yao M.; Wu S.-J.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2006 |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Tien H.-F.; Yeh Y.-C.; Wang C.-H.; Shen M.-C.; Chen Y.-C.; Tsay W.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Yao M.; Chou W.-C.; Tang J.-L.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:57Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Tien H.-F.; Wang C.-H.; Yeh Y.-C.; Shen M.-C.; Chen Y.-C.; Tsay W.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; MING YAO; Chou W.-C.; Tang J.-L.; Chen C.-Y. |
| 臺大學術典藏 |
2006 |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Wu S.-J.; Yao M.; Chou W.-C.; JIH-LUH TANG; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:48Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Wu S.-J.;Yao M.;Wen-Chien Chou;Tang J.-L.;Chen C.-Y.;Ko B.-S.;Huang S.-Y.;Tsay W.;Chen Y.-C.;Shen M.-C.;Wang C.-H.;Yeh Y.-C.;Tien H.-F.; Wu S.-J.; Yao M.; WEN-CHIEN CHOU; Tang J.-L.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-25T06:35:58Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Wu S.-J.; Yao M.; Chou W.-C.; Tang J.-L.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; MING-CHING SHEN; Wang C.-H.; Yeh Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-05-26T09:08:12Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Wu S.-J.; Yao M.; Chou W.-C.; Tang J.-L.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Tsay W.; YAO-CHANG CHEN; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; Tien H.-F. |
| 國家衛生研究院 |
2015-02-13 |
Clinical implications of species identification in monomicrobial Aeromonas bacteremia
|
Wu, CJ;Chen, PL;Hsueh, PR;Chang, MC;Tsai, PJ;Shih, HI;Wang, HC;Chou, PH;Ko, WC |
| 臺大學術典藏 |
2018-09-10T15:24:01Z |
Clinical implications of species identification in monomicrobial Aeromonas bacteremia
|
Wu, C.-J. and Chen, P.-L. and Hsueh, P.-R. and Chang, M.-C. and Tsai, P.-J. and Shih, H.-I. and Wang, H.-C. and Chou, P.-H. and Ko, W.-C.; PO-REN HSUEH |
| 臺大學術典藏 |
2015 |
Clinical implications of species identification in monomicrobial Aeromonas bacteremia
|
Chang M.-C.; Tsai P.-J.; Shih H.-I.; Wang H.-C.; Chou P.-H.; Ko W.-C.; PO-REN HSUEH; Chen P.-L.; Ko W.-C.;Chou P.-H.;Wang H.-C.;Shih H.-I.;Tsai P.-J.;Chang M.-C.;PO-REN HSUEH;Chen P.-L.;Wu C.-J.; Wu C.-J. |
| 臺大學術典藏 |
2015 |
Clinical implications of species identification in monomicrobial Aeromonas bacteremia
|
PO-REN HSUEH; Chen P.-L.; Wu C.-J.; Chang M.-C.; Tsai P.-J.; Shih H.-I.; Wang H.-C.; Chou P.-H.; Ko W.-C. |
